Hayakawa M, Maki M
Department of Obstetrics and Gynecology, Akita University School of Medicine, Akita City, Japan.
Gynecol Obstet Invest. 1988;26(3):181-90. doi: 10.1159/000293693.
The relationship between the hemostatic system and the severity of toxemia was studied in 78 pregnant women with toxemia. The activities of plasma antithrombin III (AT-III), prekallikrein, plasminogen, alpha 2-plasmin inhibitor and factor XIII were determined using the chromogenic substrate and fluorescent methods. The antigens of both AT-III and factor XIII were determined by the single radial immunodiffusion method. Plasma bradykinin was determined by radioimmunoassay. The main results obtained were as follows. Both activities of AT-III and plasma prekallikrein decreased as the gestosis index increased (p less than 0.001), and a significant negative correlation was observed between the total score of the gestosis index and AT-III (r = -0.447, p less than 0.005) or plasma prekallikrein (r = -0.434, p less than 0.005). The levels of plasminogen, alpha 2-plasmin inhibitor and factor XIII decreased and plasma bradykinin increased in toxemia. Among the various factors, plasma AT-III and prekallikrein were the most sensitive indicators of the severity of toxemia.
对78例患毒血症的孕妇研究了止血系统与毒血症严重程度之间的关系。采用发色底物法和荧光法测定血浆抗凝血酶III(AT-III)、前激肽释放酶、纤溶酶原、α2-纤溶酶抑制剂和因子XIII的活性。采用单向放射免疫扩散法测定AT-III和因子XIII的抗原。采用放射免疫分析法测定血浆缓激肽。获得的主要结果如下。随着妊娠中毒症指数升高,AT-III和血浆前激肽释放酶的活性均降低(p<0.001),并且在妊娠中毒症指数总分与AT-III(r = -0.447,p<0.005)或血浆前激肽释放酶(r = -0.434,p<0.005)之间观察到显著的负相关。毒血症时纤溶酶原、α2-纤溶酶抑制剂和因子XIII水平降低,血浆缓激肽升高。在各种因素中,血浆AT-III和前激肽释放酶是毒血症严重程度最敏感的指标。